Jen and Rebecca has been / is going nuts for having that asset and these 2 ladies are top experts, why isn't Hopper able to attract big pharma, now a big obstacle taken out of the way. I am not talking a $billion offer like after ph2 but nobody coughing up a lousy AUD 100m / USD 65m makes me thinking whether we or they are the idiots.
This is much easier to sell to big pharma than a fridge to eskimos and believe me, most of them got one.
GLTA
- Forums
- ASX - By Stock
- CHM
- Ann: First patient dosed in Phase 1/2 trial of CHM CDH17
Ann: First patient dosed in Phase 1/2 trial of CHM CDH17, page-6
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CHM (ASX) Chart |
Day chart unavailable